• Users Online: 53
  • Print this page
  • Email this page
Year : 2020  |  Volume : 6  |  Issue : 3  |  Page : 137-139

Pulmonary embolism after successful COVID-19 treatment

Department of Cardiology, Bakirkoy Dr Sadi Konuk Training and Research Hospital, Istanbul, Turkey

Correspondence Address:
Dr. Fatma Nihan Turhan Caglar
Bakirkoy Dr Sadi Konuk Training and Research Hospital, Zuhuratbaba, Istanbul
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/IJCA.IJCA_24_20

Rights and Permissions

The novel COVID-19-related disorders have become a global health problem since the pandemic emerged in China. Herein, we present a case of late pulmonary embolism development after successful COVID-19 treatment. A 45-year-old male was admitted to the emergency department with shortness of breath. He was diagnosed with mild COVID-19 pneumonia 10 days ago which was treated with hydroxychloroquine and oseltamivir for 5 days. He did not receive anticoagulation during this period. His second polymerase chain reaction test for COVID-19 came negative at the day before the second admission. He was diagnosed with pulmonary embolism and received anticoagulation therapy with heparin. COVID-19-related complications appear to still happen after treatment. Hence, follow-up of these patients is essential in order to reduce the burden of COVID-19. Thromboprophylaxis is certainly required during hospitalization. Moreover, the duration of thromboprophylaxis may be extended in some patients.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded132    
    Comments [Add]    

Recommend this journal